Notice: This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends FLKS vs. FBLG, RLMD, OPTN, ACET, PYRGF, ASRT, RGLS, ORMP, TLSA, and LPTXShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include FibroBiologics (FBLG), Relmada Therapeutics (RLMD), OptiNose (OPTN), Adicet Bio (ACET), PyroGenesis Canada (PYRGF), Assertio (ASRT), Regulus Therapeutics (RGLS), Oramed Pharmaceuticals (ORMP), Tiziana Life Sciences (TLSA), and Leap Therapeutics (LPTX). Flex Pharma vs. FibroBiologics Relmada Therapeutics OptiNose Adicet Bio PyroGenesis Canada Assertio Regulus Therapeutics Oramed Pharmaceuticals Tiziana Life Sciences Leap Therapeutics Flex Pharma (NASDAQ:FLKS) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, community ranking, earnings, media sentiment, analyst recommendations and profitability. Does the MarketBeat Community favor FLKS or FBLG? Flex Pharma received 358 more outperform votes than FibroBiologics when rated by MarketBeat users. However, 100.00% of users gave FibroBiologics an outperform vote while only 73.23% of users gave Flex Pharma an outperform vote. CompanyUnderperformOutperformFlex PharmaOutperform Votes36173.23% Underperform Votes13226.77% FibroBiologicsOutperform Votes3100.00% Underperform VotesNo Votes Do institutionals & insiders have more ownership in FLKS or FBLG? 14.4% of Flex Pharma shares are owned by institutional investors. 7.6% of Flex Pharma shares are owned by insiders. Comparatively, 20.8% of FibroBiologics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is FLKS or FBLG more profitable? FibroBiologics has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. FibroBiologics' return on equity of 0.00% beat Flex Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Flex Pharma-1,208.42% -98.04% -83.37% FibroBiologics N/A N/A N/A Do analysts prefer FLKS or FBLG? FibroBiologics has a consensus target price of $12.00, suggesting a potential upside of 302.68%. Given FibroBiologics' higher probable upside, analysts plainly believe FibroBiologics is more favorable than Flex Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flex Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AFibroBiologics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Does the media prefer FLKS or FBLG? In the previous week, FibroBiologics had 14 more articles in the media than Flex Pharma. MarketBeat recorded 14 mentions for FibroBiologics and 0 mentions for Flex Pharma. FibroBiologics' average media sentiment score of 0.56 beat Flex Pharma's score of 0.00 indicating that FibroBiologics is being referred to more favorably in the news media. Company Overall Sentiment Flex Pharma Neutral FibroBiologics Positive Which has better earnings & valuation, FLKS or FBLG? FibroBiologics has lower revenue, but higher earnings than Flex Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlex Pharma$840K31.84-$21.92MN/AN/AFibroBiologicsN/AN/A-$16.49MN/AN/A SummaryFibroBiologics beats Flex Pharma on 11 of the 14 factors compared between the two stocks. Ad Investing Daily2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.Click here. Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.74M$6.73B$5.01B$8.44BDividend YieldN/A7.94%7.49%4.16%P/E RatioN/A11.44125.4316.59Price / Sales31.84285.221,649.4776.80Price / CashN/A46.0936.9033.53Price / Book2.905.244.575.20Net Income-$21.92M$150.36M$113.24M$223.59M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$1.45-2.0%N/A+84.4%$26.20M$840,000.000.004FBLGFibroBiologics2.8805 of 5 stars$3.18+5.3%$12.00+277.4%N/A$106.18MN/A0.0010Upcoming EarningsAnalyst RevisionHigh Trading VolumeRLMDRelmada Therapeutics3.9442 of 5 stars$3.49+0.3%$7.50+114.9%+10.4%$105.31MN/A-1.2110News CoverageOPTNOptiNose3.3933 of 5 stars$0.68-1.5%$4.00+491.7%-45.9%$104.04M$70.99M-1.88190ACETAdicet Bio2.5021 of 5 stars$1.25-2.3%$7.50+500.0%-24.2%$103M$24.99M-0.4990PYRGFPyroGenesis CanadaN/A$0.56flatN/AN/A$102.77M$9.14M-8.0090Gap UpASRTAssertio2.0404 of 5 stars$1.03flat$3.44+233.7%-56.0%$98.20M$152.07M-0.2520Upcoming EarningsRGLSRegulus Therapeutics2.6572 of 5 stars$1.49+2.1%$10.80+624.8%+7.2%$97.55MN/A-1.1830Gap UpORMPOramed Pharmaceuticals1.716 of 5 stars$2.32-2.5%N/A+29.6%$97.03M$1.34M4.5510TLSATiziana Life Sciences1.3979 of 5 stars$0.94-4.1%N/A+42.6%$96.63MN/A0.008Gap UpLPTXLeap Therapeutics2.8857 of 5 stars$3.74flat$10.40+178.1%+106.6%$95.75M$1.50M-1.8740Upcoming EarningsPositive News Related Companies and Tools Related Companies FibroBiologics Competitors Relmada Therapeutics Competitors OptiNose Competitors Adicet Bio Competitors PyroGenesis Canada Competitors Assertio Competitors Regulus Therapeutics Competitors Oramed Pharmaceuticals Competitors Tiziana Life Sciences Competitors Leap Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FLKS) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLKS Stock Alerts